Perrigo | PRGO - Passivo Circulante





Passivo Circulante Alterar Data
AbbVie USD 43.29B 3.9B 2025-12
Abbott USD 16.5B 1.91B 2025-12
Bayer EUR 32.58B 3.63B 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Coherus Biosciences USD 140.39M 231.91M 2025-12
Corcept Therapeutics USD 166.08M 6.18M 2025-12
Dr.Reddys Laboratories INR 158.31B 7.38B 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
J&J USD 57.72B 3.59B 2026-03
Merck USD 28.63B 2.59B 2025-09
Nestle CHF 40.69B 6.13B 2025-12
Pacira USD 120.59M 13.51M 2025-12
Perrigo USD 1.01B 132.4M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Phibro Animal Health USD 282.37M 12.23M 2025-12
Prestige Brands USD 139.56M 4.95M 2025-12
Reckitt Benckiser GBP 7.94B 901M 2024-12
Sanofi EUR 30.01B 1.66B 2026-03
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12
Xeris Pharmaceuticals USD 109.57M 6.63M 2025-12
Zoetis USD 2.24B 428M 2025-12